COMMUNIQUÉS West-GlobeNewswire

FOXO TECHNOLOGIES INC. ANNOUNCES AGREEMENTS TO ACQUIRE PREFERRED STOCK CARRYING MAJORITY VOTING POWER IN LUDWIG ENTERPRISES, INC.
29/10/2026
WEST PALM BEACH, FL, Oct. 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc . (OTC: FOXO) (“FOXO” or the “Company”) today announced that it has entered into Stock Purchase Agreements to acquire shares of preferred [...]
Stryker reports third quarter 2026 operating results
29/10/2026
Portage, Michigan, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2026: Third Quarter Results Reported net sales increased 7.7% to $6.5 billion Organic net sales [...]
BioStem Technologies to Host Third Quarter 2026 Financial Results Conference Call on November 12, 2026
29/10/2026
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (Nasdaq: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
29/10/2026
Q1 revenue increased by 6% to $1.4 billion; up 7% on a core constant currency basis Q1 GAAP diluted earnings per share up 23% to $2.92; non-GAAP diluted EPS up 14% to $2.91 Returned more than $1.0 billion to [...]
Supernus Announces Third Quarter 2026 Financial Results
29/10/2026
Record total revenues of $226.8 million in the third quarter 2026, an 18% increase compared to same period last year. Combined revenues of the Company's four growth products increased to $192.2 million in the third [...]
Strom Strategies Calls for a Possible "Black Box Warning" on Al Sayed’s Medicare for All Proposal
29/10/2026
Dr. Joel Strom raises questions about expanding the ACA, patient choice and the need for clear evidence on the plan’s effects. Frisco, TX, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Strom Strategies today called for a detailed [...]
Nephros Schedules Third Quarter 2026 Financial Results Conference Call
29/10/2026
SOUTH ORANGE, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will [...]
Tarsus to Report Third Quarter 2026 Financial Results on Tuesday, November 3, 2026
29/10/2026
IRVINE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 3, 2026 to report its [...]
Cytek Biosciences to Participate in Upcoming Investor Conferences
29/10/2026
FREMONT, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor [...]
Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review Process
29/10/2026
REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of [...]
Avicanna Announces Closing of Non-Brokered Private Placement of Non-Convertible Debenture Units
29/10/2026
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, Oct. 29 [...]
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026
29/10/2026
SAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced [...]
OSE Immunotherapeutics annonce des résultats positifs complémentaires de l'étude de Phase 2 randomisée Combi-TED de Tedopi® (OSE2101) dans le cancer du poumon non à petites cellules métastatique
29/10/2026
Résultats finaux positifs pour le critère principal et plusieurs critères secondaires présentés par le Pr Federico Cappuzzo, PhD, le 25 octobre 2026 au congrès annuel de l’ European Society for Medical Oncology (ESMO) à [...]
OSE Immunotherapeutics Reports Additional Positive Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
29/10/2026
Final positive readout for primary and several secondary endpoints presented by Federico Cappuzzo, MD, PhD, on October 25, 2026, at the Annual Meeting of the European Society for Medical Oncology (ESMO) in Madrid 12- [...]
Cedar Park Packs the Parking Lot for Ally Medical ER’s Official Ribbon Cutting
29/10/2026
Neighbors, families, and community leaders filled the parking lot of the newest Ally Medical ER for an evening of food, games, and celebration CEDAR PARK, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency [...]
Mdxhealth to Release Third Quarter 2026 Financial Results on November 12
29/10/2026
Company to Host Conference Call with Live Q&A, November 12, 2026, at 4:30pm ET / 22:30 CET IRVINE, California – October 29, 2026 ( GlobeNewswire ) – Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics [...]
Assembly Biosciences Doses First Two Participants in Phase 2 Study of Oral NTCP Inhibitor ABI-6250 for Chronic Hepatitis Delta Virus
29/10/2026
– Phase 2 study will evaluate the safety, pharmacokinetics and antiviral activity of ABI-6250 in participants with chronic HDV infection – – Initial data from the Phase 2 study is expected in the fourth quarter of 2027 [...]
Trethera Selected as a 2026–2027 National Cancer Institute Investor Showcase Company
29/10/2026
LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
Retinal Robotics Pioneers Launch VisioSurgical Solutions (VSS) to Bring Compact Surgical Robots to Every Retina Surgeon
29/10/2026
LAUSANNE, Switzerland, Oct. 29, 2026 (GLOBE NEWSWIRE) -- VisioSurgical Solutions (VSS) , a Swiss medical robotics company founded by the team behind the first retinal surgery robot, today announced its launch and the [...]

Pages